This invention relates to crystal forms of aliskiren hemifumarate and
various embodiments related thereto, e.g. pharmaceutical preparations,
processes for the manufacture of the crystal forms, pharmaceuticals uses
and the like. The crystal forms have particularly advantageous properties
e.g. they are useful in the manufacture of blood-pressure lowering
pharmaceutical preparations and the like.